Morgan Stanley’s Tivity Health, Inc. Common Stock TVTY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-2,038,382
| Closed | -$65.6M | – | 8241 |
|
|
2022
Q1 | $65.6M | Sell |
2,038,382
-1,517,293
| -43% | -$41M | 0.01% | 1119 |
|
|
2021
Q4 | $94M | Buy |
3,555,675
+51,805
| +1% | +$1.32M | 0.01% | 936 |
|
|
2021
Q3 | $80.8M | Buy |
3,503,870
+2,700,648
| +336% | +$64.1M | 0.01% | 961 |
|
|
2021
Q2 | $21.1M | Sell |
803,222
-701,592
| -47% | -$17.6M | ﹤0.01% | 2087 |
|
|
2021
Q1 | $33.6M | Sell |
1,504,814
-310,737
| -17% | -$7.12M | ﹤0.01% | 1480 |
|
|
2020
Q4 | $35.6M | Sell |
1,815,551
-183,750
| -9% | -$3.05M | 0.01% | 1348 |
|
|
2020
Q3 | $28M | Sell |
1,999,301
-207,862
| -9% | -$3M | 0.01% | 1233 |
|
|
2020
Q2 | $25M | Buy |
2,207,163
+1,981,389
| +878% | +$18.1M | 0.01% | 1243 |
|
|
2020
Q1 | $1.42M | Sell |
225,774
-67,559
| -23% | -$1.09M | ﹤0.01% | 3661 |
|
|
2019
Q4 | $5.97M | Sell |
293,333
-526,087
| -64% | -$9.84M | ﹤0.01% | 3003 |
|
|
2019
Q3 | $13.6M | Sell |
819,420
-1,952,007
| -70% | -$33.8M | ﹤0.01% | 1821 |
|
|
2019
Q2 | $45.6M | Buy |
2,771,427
+2,079,309
| +300% | +$40.1M | 0.01% | 903 |
|
|
2019
Q1 | $12.2M | Buy |
692,118
+608,766
| +730% | +$13M | ﹤0.01% | 1838 |
|
|
2018
Q4 | $2.07M | Sell |
83,352
-7,466
| -8% | -$248K | ﹤0.01% | 3734 |
|
|
2018
Q3 | $2.92M | Sell |
90,818
-20,135
| -18% | -$687K | ﹤0.01% | 3689 |
|
|
2018
Q2 | $3.91M | Buy |
110,953
+21,768
| +24% | +$803K | ﹤0.01% | 3432 |
|
|
2018
Q1 | $3.54M | Sell |
89,185
-127,355
| -59% | -$4.94M | ﹤0.01% | 3423 |
|
|
2017
Q4 | $7.91M | Buy |
216,540
+115,724
| +115% | +$4.39M | ﹤0.01% | 2634 |
|
|
2017
Q3 | $4.11M | Buy |
100,816
+6,336
| +7% | +$246K | ﹤0.01% | 3179 |
|
|
2017
Q2 | $3.76M | Sell |
94,480
-35,187
| -27% | -$1.18M | ﹤0.01% | 3178 |
|
|
2017
Q1 | $3.77M | Sell |
129,667
-55,958
| -30% | -$1.48M | ﹤0.01% | 3168 |
|
|
2016
Q4 | $4.22M | Buy |
185,625
+55,279
| +42% | +$1.3M | ﹤0.01% | 3177 |
|
|
2016
Q3 | $3.45M | Buy |
130,346
+65,359
| +101% | +$1.32M | ﹤0.01% | 3026 |
|
|
2016
Q2 | $750K | Sell |
64,987
-96,623
| -60% | -$1.13M | ﹤0.01% | 4184 |
|
|
2016
Q1 | $1.63M | Buy |
161,610
+59,301
| +58% | +$666K | ﹤0.01% | 3513 |
|
|
2015
Q4 | $1.32M | Sell |
102,309
-28,092
| -22% | -$342K | ﹤0.01% | 3844 |
|
|
2015
Q3 | $1.45M | Buy |
130,401
+93,967
| +258% | +$1.15M | ﹤0.01% | 3793 |
|
|
2015
Q2 | $436K | Sell |
36,434
-30,916
| -46% | -$513K | ﹤0.01% | 4812 |
|
|
2015
Q1 | $1.33M | Buy |
67,350
+34,156
| +103% | +$714K | ﹤0.01% | 3916 |
|
|
2014
Q4 | $660K | Buy |
33,194
+4,373
| +15% | +$71.4K | ﹤0.01% | 4476 |
|
|
2014
Q3 | $462K | Buy |
28,821
+1,531
| +6% | +$26K | ﹤0.01% | 4624 |
|
|
2014
Q2 | $479K | Buy |
27,290
+2,080
| +8% | +$35.7K | ﹤0.01% | 4608 |
|
|
2014
Q1 | $431K | Sell |
25,210
-406
| -2% | -$6.25K | ﹤0.01% | 4656 |
|
|
2013
Q4 | $394K | Sell |
25,616
-6,170
| -19% | -$87.6K | ﹤0.01% | 4621 |
|
|
2013
Q3 | $588K | Sell |
31,786
-20,787
| -40% | -$376K | ﹤0.01% | 4220 |
|
|
2013
Q2 | $914K | Buy |
+52,573
| New | +$725K | ﹤0.01% | 3797 |
|
Other funds holding TVTY
BCMLT
PP
IA
Morgan Stanley's TVTY Position: Q2 2022 in Review
Morgan Stanley sold out of Tivity Health, Inc. Common Stock (TVTY) in Q2 2022, closing a stake of 2,038,382 shares — an estimated $65.6M sold.
Morgan Stanley first reported a position in TVTY in Q2 2013 and held it in 36 quarters. The position peaked at $94M in Q4 2021. 4 funds tracked by Wall St. Rank hold TVTY as of Q2 2022.
- Morgan Stanley reported no remaining Tivity Health, Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
- Morgan Stanley sold 2,038,382 Tivity Health, Inc. Common Stock shares in Q2 2022, an estimated $65.6M.
- Morgan Stanley first reported a position in Tivity Health, Inc. Common Stock in Q2 2013 and held it in 36 quarters.
- Morgan Stanley's Tivity Health, Inc. Common Stock position peaked at $94M in Q4 2021.
- 4 funds tracked by Wall St. Rank held Tivity Health, Inc. Common Stock as of Q2 2022.
Based on Morgan Stanley's 13F filing for Q2 2022, filed 15 Aug 2022.